GSQRX
Price
$35.70
Change
+$0.57 (+1.62%)
Updated
Dec 3 closing price
Net Assets
900.89M
UBVVX
Price
$84.71
Change
+$0.73 (+0.87%)
Updated
Dec 3 closing price
Net Assets
9.24B
Interact to see
Advertisement

GSQRX vs UBVVX

Header iconGSQRX vs UBVVX Comparison
Open Charts GSQRX vs UBVVXBanner chart's image
Goldman Sachs Small Cap Value R
Price$35.70
Change+$0.57 (+1.62%)
VolumeN/A
Net Assets900.89M
Undiscovered Managers Behavioral Val R5
Price$84.71
Change+$0.73 (+0.87%)
VolumeN/A
Net Assets9.24B
GSQRX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
GSQRX vs. UBVVX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSQRX is a Buy and UBVVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 9.24B vs. GSQRX (901M). UBVVX pays higher dividends than GSQRX: UBVVX (1.84) vs GSQRX (0.90). GSQRX was incepted earlier than UBVVX: GSQRX (18 years) vs UBVVX (9 years). GSQRX (1.68) is less costly to investors than UBVVX (0.95). GSQRX is a more actively managed with annual turnover of: 83.00 vs. UBVVX (35.00). GSQRX (0) and UBVVX (0) have matching initial minimum investment requirements. UBVVX annual gain was more profitable for investors over the last year : -8.12 vs. GSQRX (-16.84). UBVVX return over 5 years is better than : 39.70 vs. GSQRX (-24.40).
GSQRXUBVVXGSQRX / UBVVX
Total Expense Ratio1.500.90167%
Annual Report Gross Expense Ratio1.680.95177%
Fund Existence18 years9 years-
Gain YTD11.0420.8691,270%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets901M9.24B10%
Annual Yield % from dividends0.901.8449%
Returns for 1 year-16.84-8.12208%
Returns for 3 years-19.682.58-762%
Returns for 5 years-24.4039.70-61%
Returns for 10 years-27.48N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACLS88.025.59
+6.78%
Axcelis Technologies
CEVA22.070.79
+3.71%
CEVA
MTZ218.295.31
+2.49%
MasTec
QIPT2.420.03
+1.26%
Quipt Home Medical Corp
FGL0.36-0.01
-1.51%
Founder Group Ltd